Le Lézard
Classified in: Health

CloudSpeech: Changing the speech therapy landscape through modern approaches with traditional values


CloudSpeech is excited to accept private insurance in California. Speech therapy has never been more accessible. The future is now.

SAN FRANCISCO, March 29, 2024 /PRNewswire-PRWeb/ -- Bringing the Clinic to You.

Bringing the clinic to you!

And now accepting private insurance plans! For even more access to the support your child needs.

CloudSpeech is a private practice offering services online in Texas, California, and New York since 2019.

We like to think of ourselves as one of the trendsetters who saw the opportunity for a more convenient and comfortable approach to speech therapy before it became the new normal.

WEEKEND AND AFTER SCHOOL HOURS AVAILABLE

FIND SUPPORT ACROSS MANY ZIP CODES

We believe that teletherapy opens doors for people to connect with the support they need regardless of their zip code. Our clients can reach us directly from their farmhouse in rural Texas, their city sky rise in busy downtown New York, or their cozy apartment in San Francisco.

TELETHERAPY GIVES THE GIFT OF TIME

Teletherapy creates time for our active families! Save that commute time for a walk to the park, or carry the iPad with you to grandma's after dance class on Tuesdays to keep up with regular sessions. We can flow with you.

Media Contact

Christina Ann Burnham, CloudSpeech: Online Therapy, 1 (512) 765-4554, [email protected], www.cloudspeech.com

LinkedIn

SOURCE CloudSpeech: Online Therapy


These press releases may also interest you

at 01:00
April 29, 2024 First-quarter highlights Group sales amounted to EUR 4.1 billion, with comparable sales growth of 2.4%Comparable order intake -3.8%, mainly due to ChinaUSD 1.1 billion Respironics litigation settlement reached in the US...

at 00:45
4P-Pharma, a Lille-based clinical-stage startup studio focused on developing curative therapies for untreated serious diseases, announces that it has successfully secured a total capital of ?15 million in its second closing with participation from...

at 00:20
PROTEINA announced today that it has held a kickoff meeting with Professor Janghee Woo and his research team at Emory University School of Medicine in Atlanta, to begin global clinical validation of its flagship product, PPI PathFinder BCL2 Dx. PPI...

at 00:00
Building on its commitment to identify strengths and gaps in the R&D pipeline for antivirals, the INTREPID Alliance, a consortium of innovative biopharmaceutical companies dedicated to accelerating antiviral treatments to help protect the world ahead...

at 00:00
Spectrum Dynamic's customers will...

28 avr 2024
AriBio Co., Ltd. (AriBio) announced authorisation from the European Medicines Agency (EMA) for POLARIS-AD (AR1001-ADP3-US01), a global, phase 3, early Alzheimer's disease clinical trial. EMA now aligns with the U.S. Food and Drug Administration (FDA)...



News published on and distributed by: